XWELL EBITDA Margin 2010-2025 | XWEL
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for XWELL (XWEL) over the last 10 years. The current EBITDA margin for XWELL as of March 31, 2025 is .
| XWELL EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.03B | $-0.02B | -48.39% |
| 2024-12-31 | $0.03B | $-0.01B | -42.42% |
| 2024-09-30 | $0.03B | $-0.01B | -15.15% |
| 2024-06-30 | $0.03B | $-0.01B | -37.50% |
| 2024-03-31 | $0.03B | $-0.02B | -48.39% |
| 2023-12-31 | $0.03B | $-0.02B | -62.07% |
| 2023-09-30 | $0.03B | $-0.03B | -106.67% |
| 2023-06-30 | $0.03B | $-0.03B | -79.41% |
| 2023-03-31 | $0.04B | $-0.03B | -72.50% |
| 2022-12-31 | $0.06B | $-0.03B | -43.86% |
| 2022-09-30 | $0.08B | $-0.01B | -12.82% |
| 2022-06-30 | $0.09B | $0.00B | 4.26% |
| 2022-03-31 | $0.09B | $0.01B | 7.87% |
| 2021-12-31 | $0.07B | $0.01B | 10.81% |
| 2021-09-30 | $0.05B | $-0.01B | -26.67% |
| 2021-06-30 | $0.02B | $-0.03B | -150.00% |
| 2021-03-31 | $0.01B | $-0.03B | -344.44% |
| 2020-12-31 | $0.01B | $-0.03B | -400.00% |
| 2020-09-30 | $0.02B | $-0.02B | -126.32% |
| 2020-06-30 | $0.03B | $-0.02B | -46.88% |
| 2020-03-31 | $0.05B | $-0.01B | -20.00% |
| 2019-12-31 | $0.05B | $-0.01B | -16.33% |
| 2019-09-30 | $0.05B | $0.00B | -4.00% |
| 2019-06-30 | $0.05B | $-0.01B | -10.00% |
| 2019-03-31 | $0.05B | $-0.01B | -10.00% |
| 2018-12-31 | $0.05B | $-0.01B | -13.73% |
| 2018-09-30 | $0.05B | $-0.01B | -9.80% |
| 2018-06-30 | $0.05B | $-0.01B | -11.76% |
| 2018-03-31 | $0.05B | $-0.01B | -11.76% |
| 2017-12-31 | $0.05B | $-0.01B | -14.29% |
| 2017-09-30 | $0.03B | $0.01B | 15.63% |
| 2017-06-30 | $0.02B | $-0.01B | -31.82% |
| 2017-03-31 | $0.02B | $0.00B | -15.00% |
| 2016-12-31 | $0.01B | $0.00B | -18.18% |
| 2016-09-30 | $0.04B | $0.00B | 7.69% |
| 2015-12-31 | $0.02B | $0.00B | -17.39% |
| 2015-03-31 | $0.00B | $-0.04B | -3700.00% |
| 2014-12-31 | $0.00B | $-0.04B | -4000.00% |
| 2014-03-31 | $0.00B | $-0.04B | -3500.00% |
| 2013-06-30 | $0.00B | $-0.03B | -3300.00% |
| 2011-06-30 | $0.00B | $-0.01B | 0.00% |
| 2011-03-31 | $0.00B | $-0.01B | 0.00% |
| 2010-12-31 | $0.00B | $-0.01B | 0.00% |
| 2010-06-30 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.005B | $0.034B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.077B | 27.58 |
| CVS Health (CVS) | United States | $83.011B | 10.32 |
| Elevance Health (ELV) | United States | $78.142B | 10.08 |
| Cencora (COR) | United States | $57.628B | 20.05 |
| DiDi Global (DIDIY) | China | $23.768B | 25.25 |
| Natera (NTRA) | United States | $22.306B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.229B | 17.22 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.751B | 0.00 |
| Solventum (SOLV) | United States | $13.128B | 13.90 |
| CochLear (CHEOY) | Australia | $12.788B | 0.00 |
| ICON (ICLR) | Ireland | $12.281B | 11.42 |
| Revvity (RVTY) | United States | $12.070B | 20.77 |
| Viatris (VTRS) | United States | $10.857B | 3.73 |
| Medpace Holdings (MEDP) | United States | $9.434B | 25.06 |
| Avantor (AVTR) | United States | $9.336B | 13.56 |
| Sonic Healthcare (SKHHY) | Australia | $8.582B | 0.00 |
| HealthEquity (HQY) | United States | $8.405B | 36.81 |
| Charles River Laboratories (CRL) | United States | $8.038B | 15.75 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.772B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.024B | 29.58 |
| BrightSpring Health Services (BTSG) | United States | $3.667B | 33.65 |
| Sotera Health (SHC) | United States | $3.375B | 19.18 |
| Surgery Partners (SGRY) | United States | $2.855B | 37.12 |
| Alignment Healthcare (ALHC) | United States | $2.647B | 0.00 |
| Concentras Parent (CON) | United States | $2.621B | 15.15 |
| Organon (OGN) | United States | $2.605B | 2.77 |
| GeneDx Holdings (WGS) | United States | $2.480B | 95.51 |
| Ardent Health (ARDT) | United States | $2.041B | 8.70 |
| Progyny (PGNY) | United States | $2.024B | 44.55 |
| PACS (PACS) | United States | $1.949B | 0.00 |
| Premier (PINC) | United States | $1.767B | 13.41 |
| GoodRx Holdings (GDRX) | United States | $1.750B | 35.00 |
| Teladoc Health (TDOC) | United States | $1.546B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.329B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.160B | 8.82 |
| CareDx (CDNA) | United States | $1.149B | 17.94 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.846B | 7.92 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 290.00 |
| Nutex Health (NUTX) | United States | $0.653B | 9.89 |
| Embecta (EMBC) | United States | $0.627B | 4.22 |
| InnovAge Holding (INNV) | United States | $0.567B | 0.00 |
| SBC Medicals (SBC) | United States | $0.552B | 0.00 |
| LifeMD (LFMD) | United States | $0.544B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.486B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.60 |
| Omada Health (OMDA) | $0.461B | 0.00 | |
| So-Young (SY) | China | $0.389B | 0.00 |
| Enhabit (EHAB) | United States | $0.375B | 30.88 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.348B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.338B | 0.00 |
| Beauty Health (SKIN) | United States | $0.257B | 0.00 |
| Oncology Institute (TOI) | United States | $0.256B | 0.00 |
| DocGo (DCGO) | United States | $0.153B | 25.00 |
| Pheton Holdings (PTHL) | China | $0.134B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.104B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.055B | 0.00 |
| ModivCare (MODV) | United States | $0.054B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.023B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |